Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007780-02
Application #
2213011
Study Section
Research Training Review Committee (RTR)
Project Start
1994-07-01
Project End
1999-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Cantor, Joshua P; Iliopoulos, Dimitrios; Rao, Atul S et al. (2007) Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Int J Cancer 120:24-31
Semba, Shuho; Han, Shuang-Yin; Qin, Haiyan R et al. (2006) Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor. J Biol Chem 281:28244-53
Semba, S; Trapasso, F; Fabbri, M et al. (2006) Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential. Oncogene 25:2860-72
Wermuth, Peter J; Buchberg, Arthur M (2005) Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines. Blood 105:1222-30
Iliopoulos, Dimitrios; Guler, Gulnur; Han, Shuang-Yin et al. (2005) Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene 24:1625-33
Ottey, M; Han, S-Y; Druck, T et al. (2004) Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant. Br J Cancer 91:1669-77
Tungaturthi, Parithosh K; Sawaya, Bassel E; Ayyavoo, Velpandi et al. (2004) HIV-1 Vpr: genetic diversity and functional features from the perspective of structure. DNA Cell Biol 23:207-22
Tungaturthi, Parithosh K; Sawaya, Bassel E; Singh, Satya P et al. (2003) Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. Biomed Pharmacother 57:20-4
Powzaniuk, M A; Trotta, R; Loza, M J et al. (2001) B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells. J Immunol 167:242-9
MacLachlan, T K; Giordano, A (1998) TRAF2 expression in differentiated muscle. J Cell Biochem 71:461-6

Showing the most recent 10 out of 16 publications